Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China
· Delayed Price · Currency is CNY 24.14
-0.13 (-0.54%)
Jul 2, 2025, 2:45 PM CST
SHE:300702 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,685 | 2,615 | 2,521 | 2,651 | 2,529 | 2,586 | Upgrade
|
Other Revenue | 15.64 | 15.64 | 6.74 | 15.33 | 16.49 | 1.37 | Upgrade
|
| 2,701 | 2,631 | 2,527 | 2,667 | 2,545 | 2,587 | Upgrade
| |
Revenue Growth (YoY) | 10.71% | 4.10% | -5.23% | 4.78% | -1.64% | 22.59% | Upgrade
|
Cost of Revenue | 1,790 | 1,761 | 1,677 | 2,076 | 1,638 | 1,297 | Upgrade
|
Gross Profit | 910.19 | 869.86 | 849.83 | 591.07 | 907.42 | 1,290 | Upgrade
|
Selling, General & Admin | 509.34 | 500.32 | 425.45 | 423.79 | 465.02 | 361.41 | Upgrade
|
Research & Development | 242.29 | 238.9 | 243.82 | 231.1 | 227.4 | 179.07 | Upgrade
|
Other Operating Expenses | 21.15 | 20.91 | 28.17 | 19.72 | 24.14 | 26.16 | Upgrade
|
Operating Expenses | 775.28 | 758.76 | 703.74 | 670.74 | 721.58 | 571.01 | Upgrade
|
Operating Income | 134.91 | 111.1 | 146.09 | -79.67 | 185.84 | 719.41 | Upgrade
|
Interest Expense | -51.14 | -54.07 | -49.91 | -33.85 | -16.33 | -4.41 | Upgrade
|
Interest & Investment Income | 10.22 | 19.88 | 6.07 | 7.22 | 75.73 | 29.84 | Upgrade
|
Currency Exchange Gain (Loss) | 25.18 | 25.18 | 8.83 | 37.92 | -10.58 | -36.24 | Upgrade
|
Other Non Operating Income (Expenses) | -4.21 | -4.85 | -2.3 | -1.28 | -1.12 | -1.18 | Upgrade
|
EBT Excluding Unusual Items | 114.96 | 97.24 | 108.78 | -69.66 | 233.55 | 707.42 | Upgrade
|
Gain (Loss) on Sale of Investments | -10.5 | -30.4 | -62.69 | -59.65 | -12.97 | 42.64 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.98 | 0.72 | -0.03 | -0.02 | 0.06 | 0.21 | Upgrade
|
Asset Writedown | -8.5 | -2.67 | -2.09 | -8.21 | -16.09 | -5.51 | Upgrade
|
Other Unusual Items | 17.7 | 13.75 | 27.64 | 26.76 | 13.85 | 24.13 | Upgrade
|
Pretax Income | 114.64 | 78.64 | 71.92 | -110.5 | 218.41 | 768.88 | Upgrade
|
Income Tax Expense | 13.04 | 22.7 | 44.56 | 8.37 | 13.73 | 101.82 | Upgrade
|
Net Income | 101.6 | 55.94 | 27.36 | -118.87 | 204.68 | 667.06 | Upgrade
|
Net Income to Common | 101.6 | 55.94 | 27.36 | -118.87 | 204.68 | 667.06 | Upgrade
|
Net Income Growth | - | 104.45% | - | - | -69.32% | 13.89% | Upgrade
|
Shares Outstanding (Basic) | 350 | 350 | 342 | 350 | 347 | 324 | Upgrade
|
Shares Outstanding (Diluted) | 350 | 350 | 342 | 350 | 347 | 325 | Upgrade
|
Shares Change (YoY) | 2.02% | 2.22% | -2.18% | 0.78% | 6.61% | -0.62% | Upgrade
|
EPS (Basic) | 0.29 | 0.16 | 0.08 | -0.34 | 0.59 | 2.06 | Upgrade
|
EPS (Diluted) | 0.29 | 0.16 | 0.08 | -0.34 | 0.59 | 2.05 | Upgrade
|
EPS Growth | - | 100.00% | - | - | -71.22% | 14.60% | Upgrade
|
Free Cash Flow | 90.31 | 175.69 | -360.71 | -575.71 | -998.62 | 116.13 | Upgrade
|
Free Cash Flow Per Share | 0.26 | 0.50 | -1.05 | -1.65 | -2.88 | 0.36 | Upgrade
|
Dividend Per Share | 0.050 | 0.050 | 0.050 | - | 0.100 | 0.278 | Upgrade
|
Dividend Growth | - | - | - | - | -64.00% | - | Upgrade
|
Gross Margin | 33.70% | 33.06% | 33.63% | 22.17% | 35.66% | 49.87% | Upgrade
|
Operating Margin | 5.00% | 4.22% | 5.78% | -2.99% | 7.30% | 27.80% | Upgrade
|
Profit Margin | 3.76% | 2.13% | 1.08% | -4.46% | 8.04% | 25.78% | Upgrade
|
Free Cash Flow Margin | 3.34% | 6.68% | -14.27% | -21.59% | -39.24% | 4.49% | Upgrade
|
EBITDA | 463.25 | 432.5 | 439.74 | 164.56 | 371.04 | 855.5 | Upgrade
|
EBITDA Margin | 17.15% | 16.44% | 17.40% | 6.17% | 14.58% | 33.06% | Upgrade
|
D&A For EBITDA | 328.33 | 321.4 | 293.65 | 244.23 | 185.2 | 136.1 | Upgrade
|
EBIT | 134.91 | 111.1 | 146.09 | -79.67 | 185.84 | 719.41 | Upgrade
|
EBIT Margin | 5.00% | 4.22% | 5.78% | -2.99% | 7.30% | 27.80% | Upgrade
|
Effective Tax Rate | 11.37% | 28.87% | 61.96% | - | 6.29% | 13.24% | Upgrade
|
Revenue as Reported | 2,701 | 2,631 | 2,527 | 2,667 | 2,545 | 2,587 | Upgrade
|
Advertising Expenses | - | 61.43 | 67.59 | 12.92 | 0.97 | 0.87 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.